Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

Lymph node evaluation is a critical component in the staging and treatment of colorectal cancer (CRC). The number of lymph nodes examined during surgical procedures can significantly influence ...

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

About a third of cases are diagnosed before the cancer has spread outside of the colon or rectum, while 10 percent of cases were only identified after it had spread to lymph nodes, tissues and ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients found that patients with evidence of residual cancer in their blood after surgery to remove the cancer, may benefit ...

Risk of residual tumor following removal of a malignant colorectal polyp with high-risk features. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

At stage 1, colon cancer has not yet grown deeply into nearby tissues or metastasized (spread) to lymph nodes. Early symptoms are likely and include bowel habit changes, blood in the stool ...

Stage 3 bowel (colon and rectal) cancer has spread to nearby lymph nodes, but hasn't spread to distant body parts. It's divided into 3 groups - 3A, 3B and 3C. You have surgery to remove your cancer.